Literature DB >> 19017537

Dopamine receptor-mediated regulation of neuronal "clock" gene expression.

M Imbesi1, S Yildiz, A Dirim Arslan, R Sharma, H Manev, T Uz.   

Abstract

Using a transgenic mice model (i.e. "clock" knockouts), clock transcription factors have been suggested as critical regulators of dopaminergic behaviors induced by drugs of abuse. Moreover, it has been shown that systemic administration of psychostimulants, such as cocaine and methamphetamine regulates the striatal expression of clock genes. However, it is not known whether dopamine receptors mediate these regulatory effects of psychostimulants at the cellular level. Primary striatal neurons in culture express dopamine receptors as well as clock genes and have been successfully used in studying dopamine receptor functioning. Therefore, we investigated the role of dopamine receptors on neuronal clock gene expression in this model using specific receptor agonists. We found an inhibitory effect on the expression of mClock and mPer1 genes with the D2-class (i.e. D2/D3) receptor agonist quinpirole. We also found a generalized stimulatory effect on the expression of clock genes mPer1, mClock, mNPAS2 (neuronal PAS domain protein 2), and mBmal1 with the D1-class (i.e. D1) receptor agonist SKF38393. Further, we tested whether systemic administration of dopamine receptor agonists causes similar changes in striatal clock gene expression in vivo. We found quinpirole-induced alterations in mPER1 protein levels in the mouse striatum (i.e. rhythm shift). Collectively, our results indicate that the dopamine receptor system may mediate psychostimulant-induced changes in clock gene expression. Using striatal neurons in culture as a model, further research is needed to better understand how dopamine signaling modulates the expression dynamics of clock genes (i.e. intracellular signaling pathways) and thereby influences neuronal gene expression, neuronal transmission, and brain functioning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017537      PMCID: PMC3664916          DOI: 10.1016/j.neuroscience.2008.10.044

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  37 in total

Review 1.  Addiction and the brain: the neurobiology of compulsion and its persistence.

Authors:  S E Hyman; R C Malenka
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

2.  Expression of the Per1 gene in the hamster: brain atlas and circadian characteristics in the suprachiasmatic nucleus.

Authors:  S Yamamoto; Y Shigeyoshi; Y Ishida; T Fukuyama; S Yamaguchi; K Yagita; T Moriya; S Shibata; N Takashima; H Okamura
Journal:  J Comp Neurol       Date:  2001-02-19       Impact factor: 3.215

3.  Forskolin induces circadian gene expression of rPer1, rPer2 and dbp in mammalian rat-1 fibroblasts.

Authors:  K Yagita; H Okamura
Journal:  FEBS Lett       Date:  2000-01-07       Impact factor: 4.124

4.  Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.

Authors:  T Nikaido; M Akiyama; T Moriya; S Shibata
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

5.  Clock gene protein mPER1 is rhythmically synthesized and under cAMP control in the mouse pineal organ.

Authors:  C von Gall; I Schneider-Hüther; M Pfeffer; F Dehghani; H W Korf; J H Stehle
Journal:  J Neuroendocrinol       Date:  2001-04       Impact factor: 3.627

6.  Transactivation mechanisms of mouse clock transcription factors, mClock and mArnt3.

Authors:  S Takahata; T Ozaki; J Mimura; Y Kikuchi; K Sogawa; Y Fujii-Kuriyama
Journal:  Genes Cells       Date:  2000-09       Impact factor: 1.891

7.  The 5' upstream region of mPer1 gene contains two promoters and is responsible for circadian oscillation.

Authors:  S Yamaguchi; S Mitsui; S Miyake; L Yan; H Onishi; K Yagita; M Suzuki; S Shibata; M Kobayashi; H Okamura
Journal:  Curr Biol       Date:  2000-07-13       Impact factor: 10.834

8.  Circadian modulation of dopamine receptor responsiveness in Drosophila melanogaster.

Authors:  R Andretic; J Hirsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

9.  Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.

Authors:  J Viyoch; S Ohdo; E Yukawa; S Higuchi
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

10.  Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats.

Authors:  S Masubuchi; S Honma; H Abe; K Ishizaki; M Namihira; M Ikeda; K Honma
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

View more
  44 in total

1.  Cell-Type-Specific Regulation of Nucleus Accumbens Synaptic Plasticity and Cocaine Reward Sensitivity by the Circadian Protein, NPAS2.

Authors:  Puja K Parekh; Ryan W Logan; Kyle D Ketchesin; Darius Becker-Krail; Micah A Shelton; Mariah A Hildebrand; Kelly Barko; Yanhua H Huang; Colleen A McClung
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

Review 2.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

Review 3.  Depression research: where are we now?

Authors:  Saebom Lee; Jaehoon Jeong; Yongdo Kwak; Sang Ki Park
Journal:  Mol Brain       Date:  2010-03-10       Impact factor: 4.041

4.  Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.

Authors:  Angela R Ozburn; Edgardo Falcon; Alan Twaddle; Alexandria L Nugent; Andrea G Gillman; Sade M Spencer; Rachel N Arey; Shibani Mukherjee; James Lyons-Weiler; David W Self; Colleen A McClung
Journal:  Biol Psychiatry       Date:  2014-08-13       Impact factor: 13.382

Review 5.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 6.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

Review 7.  Minutes, days and years: molecular interactions among different scales of biological timing.

Authors:  Diego A Golombek; Ivana L Bussi; Patricia V Agostino
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-01-20       Impact factor: 6.237

8.  Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain.

Authors:  Luciana Gravotta; Alex M Gavrila; Suzanne Hood; Shimon Amir
Journal:  J Mol Neurosci       Date:  2011-04-12       Impact factor: 3.444

Review 9.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

10.  A verification of previously identified QTLs for cocaine-induced activation using a panel of B6.A chromosome substitution strains (CSS) and A/J x C57Bl/6J F2 mice.

Authors:  Alan E Boyle; Kathryn J Gill
Journal:  Psychopharmacology (Berl)       Date:  2009-09-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.